Related Experiment Video
Updated: Jun 26, 2026
06:08
Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model
Published on: February 10, 2023
Hyperammonaemic encephalopathy associated with rituximab-containing chemotherapy
1Department of Oncology, The Queen Elizabeth Hospital, Adelaide, Australia.
Internal Medicine Journal
|January 16, 2009
Summary
Hyperammonaemic encephalopathy is a rare complication of chemotherapy, particularly when combined with rituximab. Early diagnosis is crucial for patients experiencing unexplained neurological symptoms during cancer treatment.
Area of Science:
- Oncology
- Neurology
- Pharmacology
Background:
- Hyperammonaemic encephalopathy (HE) is an uncommon but serious complication following chemotherapy for various cancers.
- While reported with standard and high-dose regimens, its association with newer therapies like rituximab is less understood.
Observation:
- This case report details a patient experiencing HE in conjunction with rituximab-containing chemotherapy.
- The patient presented with unexplained behavioral changes and encephalopathy, prompting investigation into potential causes.
Findings:
- This is the first reported instance of hyperammonaemic encephalopathy associated with rituximab-containing chemotherapy.
- The findings highlight a potential neurotoxic side effect of this specific chemotherapeutic combination.
Implications:
- Clinicians should consider HE in patients on rituximab-based chemotherapy who exhibit neurological symptoms.
- Early recognition and diagnosis of HE are vital for timely intervention and improved patient outcomes.
- Further research is warranted to elucidate the mechanisms and incidence of HE with rituximab.
Related Concept Videos
01:29Hepatic Encephalopathy
DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...
01:27Cryptococcal Meningitis
Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
01:19Encephalitis l: Introduction
Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...
01:26Rocky Mountain Spotted Fever
Rocky Mountain Spotted Fever (RMSF) is a severe tick-borne illness caused by Rickettsia rickettsii, a Gram-negative, coccobacillary bacterium. This pathogen is an obligate intracellular parasite, requiring a host cell for replication. Transmission occurs through the bite of an infected tick. In the United States, the most important vectors are Dermacentor variabilis (American dog tick) and Dermacentor andersoni (Rocky Mountain wood tick), though other tick species may also serve as vectors.
01:26Encephalitis ll: Pathophysiology
Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
01:29Cardiomyopathy IV: Restrictive Cardiomyopathy
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...